Optimization of trial duration to predict long‐term HbA1c change with therapy: A pharmacometrics simulation‐based evaluation-Reference-Cited by-同舟云学术

Optimization of trial duration to predict long‐term HbA1c change with therapy: A pharmacometrics simulation‐based evaluation

Published:2022-09-07 Issue:11 Volume:11 Page:1443-1457
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Kunina Hanna¹,Al‐Mashat Alex¹,Chien Jenny Y.²^ORCID,Garhyan Parag²,Kjellsson Maria C.¹^ORCID

Affiliation:

1. Pharmacometrics Research Group, Department of Pharmacy Uppsala University Uppsala Sweden

2. Global Pharmacokinetics/Pharmacodynamics and Pharmacometrics, Lilly Research Laboratories Lilly Corporate Center Indianapolis Indiana USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12854

Reference34 articles.

1. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

2. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

3. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) National Center for Biomedical Information. [updated 2021 May]. Available:http://clinicaltrials.gov/. Accessed 13 Jul2021.

4. Diagnosis and Classification of Diabetes Mellitus

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WhatsApp‐based intervention for people with type 2 diabetes: A randomized controlled trial;Nursing & Health Sciences;2024-04-02

2. Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial;Diabetes, Obesity and Metabolism;2023-12-15

3. Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories;Frontiers in Medicine;2023-10-12